Skip to main content
Main menu
Pipeline
Clinical
Discovery
Compounds
Regimens
Drug Targets
Developers
Trial Sites
Trials
News
Meetings
Members
Our Members
Core Group
About
Join Us
Trial
Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MAMS Design
Study Director
Start Date
4 / 2013
Trial Phase
Trial Status
all patients enrolled
Current Enrollment
Target Enrollment
365
Overview
Compound Associations
Rifampicin